Study Highlights Underrecognised Malnutrition Risk in Crohn’s Disease

Study Highlights Underrecognised Malnutrition Risk in Crohn’s Disease

A new cross-sectional study has examined nutritional status in people with Crohn’s disease (CD) using several assessment approaches together, rather than relying on a single measure. Published in PLOS ONE, the research underscores malnutrition as a common but frequently overlooked complication of CD, one that may affect patients’ daily functioning, their tolerance of treatment, and their overall quality of life.

Background Context

Crohn’s disease is a form of inflammatory bowel disease (IBD) that causes chronic inflammation anywhere along the digestive tract, most often in the small intestine and colon. Reduced appetite, malabsorption, increased nutrient losses and the metabolic demands of ongoing inflammation all contribute to a heightened risk of malnutrition in this population. Despite this, nutritional status is not always systematically assessed in routine gastroenterology care, and no single screening tool is universally agreed upon. Comparing different assessment methods side by side helps clarify which approaches best capture the true nutritional burden faced by patients, and how that burden relates to disease activity and outcomes.

Key Findings

According to the study authors, malnutrition remains a common but often underrecognised complication among people living with Crohn’s disease. The researchers applied a multidimensional approach, drawing on a combination of nutritional assessment methods rather than a single anthropometric or biochemical measure, to build a fuller picture of patients’ nutritional status. Their cross-sectional comparison suggests that nutritional deficits identified through one method are not always captured by another, pointing to gaps that a narrower assessment could miss. The authors link poorer nutritional status to broader effects on functional status, treatment tolerance and quality of life for patients with CD. The full quantitative results, including specific prevalence figures and statistical comparisons between assessment tools, were not detailed in the source material available for this summary, and are best reviewed directly in the published paper by clinicians seeking the complete dataset.

Clinical Relevance

For gastroenterologists, IBD nurses and dietitians, the findings reinforce the case for structured, multidimensional nutritional assessment as part of routine care for people with Crohn’s disease, rather than assuming that weight or body mass index alone will flag those at risk. Malnutrition in CD has been linked in the wider literature to reduced resilience during flares, slower recovery, and potential effects on how well patients tolerate medical or surgical treatment. Identifying nutritional deficits earlier, using a combination of tools, may help multidisciplinary IBD teams target dietetic support more effectively. Patients themselves may benefit from understanding that nutritional status is a recognised and monitorable aspect of their overall disease management, distinct from disease activity itself.

Reference

Multidimensional nutritional assessment in Crohn’s disease: Cross-sectional comparison of nutritional assessment methods [title incomplete in source material]. PLOS ONE. DOI: 10.1371/journal.pone.0352372. Author names and full publication date were not specified in the source material available at the time of writing; readers are advised to consult the PLOS ONE record directly for complete citation details.

This article is a journalistic summary for informational purposes only. It does not constitute clinical advice or a recommendation to alter treatment decisions.

About the Author

Team Vance

Team Vance is the editorial team at Vance Medical, the medical foods company behind this hub. Vance Medical has spent more than thirty years in gastrointestinal medicine, developing nutritional products under the same regulatory frameworks that govern prescription medicines. The Hub exists to make that ground accessible, to people living with Crohn's disease, ulcerative colitis, IBS and related conditions, and to the clinicians treating them. Articles are written and edited in-house, and clinical claims are referenced to published research, with each study linked to its DOI so you can read the source rather than take our word for it. We publish primarily for a UK audience. Nothing here replaces advice from your own GP, gastroenterologist or dietitian.

For general information only. This article is for general information and is not a substitute for professional medical advice, diagnosis or treatment. It reflects the best available evidence at the time of writing and may not capture the most recent developments. Always talk to your GP, pharmacist or healthcare team before acting on anything you read here, and never disregard professional advice or delay seeking it because of something on this site. Where we mention products from Vance Medical Foods Ltd we identify this clearly.
Last updated 7 September 2026
×
×